What does Bioethics, Ltd. do?

Bioethics, Ltd. (BOTH) operates in the Shell Companies industry within the Financial Services sector. Full company description, peers, and segment breakdown are on the page above.

What is BOTH's market cap?

Bioethics, Ltd. (BOTH) has a market capitalization of approximately $18,360, as of August 25, 2026, based on the most recent share price and shares outstanding.

Does BOTH pay a dividend?

No — Bioethics, Ltd. (BOTH) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

Bioethics, Ltd. (BOTH) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

BOTH

Bioethics, Ltd.

OTC·Shell Companies · Financial Services

$0.01$0.00+0.00%

Market cap$18.36K·Market closed·Aug 25 8:00 PM UTC

Price Chart

$0.01+$0.00 (+0.00%)today

−99.74%CAGR −69.71%

Select date range

FromTo

Jun 27, 2002Aug 27, 2021 → Aug 27, 2026· 5.0 yrsAug 27, 2026

Key Metrics

BOTH does not currently pay a dividend.

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings DateMar 31

Last Report DateSep 29

Reported vs Estimate−$0.02

Earnings Surprise—

FinancialsFinancials Tab

Revenue$0.00

Net Income−$176.96K

Net Margin—

Operating Cash Flow−$150.43K

Capital Expenditures$0.00

Free Cash Flow−$150.43K

Return on Equity—

Return on Invested Capital9.6%

Net Debt$571.03K

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for BOTH and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how BOTH's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for BOTH and 80,000+ other tickers.

About Bioethics, Ltd.

Established in 1990 and located in Ogden, Utah, Bioethics, Ltd. is not currently involved in substantial business activities. Instead, the company plans to explore, assess, and, if appropriate, acquire a stake in a new commercial enterprise.

CEO: Mark A. Scharmann
Sector: Financial Services
Industry: Shell Companies
Exchange: OTC
Employees: 1

Peers

Peers Tab

EGDD

Eastern Goldfields, Inc.

Cap

$968.0

CWNOF

Chineseworldnet.Com Inc.

Cap

$8.8K

ASPR

Adsouth Partners Inc.

Cap

$85.1K

Latest News

News Tab

No recent news available.

Frequently Asked Questions About BOTH

What does Bioethics, Ltd. do?: Bioethics, Ltd. (BOTH) operates in the Shell Companies industry within the Financial Services sector. Full company description, peers, and segment breakdown are on the page above.
What is BOTH's market cap?: Bioethics, Ltd. (BOTH) has a market capitalization of approximately $18,360, as of August 25, 2026, based on the most recent share price and shares outstanding.
Does BOTH pay a dividend?: No — Bioethics, Ltd. (BOTH) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.
Is BOTH profitable?: Bioethics, Ltd. (BOTH) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.